Table 1 Target and prescribed dose for the brain and pelvis cohorts
From: Comparison of four synthetic CT generators for brain and prostate MR-only workflow in radiotherapy
Brain (n = 42) | Target | Meningioma | 5 |
Glioma | 34 | ||
Carcinopharyngioma | 1 | ||
Astrocytoma | 2 | ||
Dose (Gy) | 60 − (30 × 2) | 28 | |
54 − (30 × 1.8) | 4 | ||
52.2 − (29 × 1.8) | 1 | ||
50.4 − (28 × 1.8) | 4 | ||
40 − (15 × 2.67) | 5 | ||
Pelvis (n = 52) | Target | Prostate alone | 10 |
Prostate and vesicles | 5 | ||
Prostate, vesicles and lymph nodes | 30 | ||
Prostate and bone metastases | 3 | ||
Prostate cavity and pelvis | 3 | ||
Pelvis | 1 | ||
Dose (Gy) | 78 − (39 × 2) | 46 | |
74 − (37 × 2) | 1 | ||
72 − (36 × 2) | 2 | ||
66 − (33 × 2) | 1 | ||
60 − (20 × 3) | 2 |